Log in to access this content.

HIV patient advocates will continue to lobby for more states to go the extra mile to protect patient access to pre-exposure prophylaxis (PrEP) medications that prevent the contraction and spread of ...

FDA has declined to grant accelerated approval status for Moderna and Merck’s mRNA-4157 melanoma vaccine candidate, currently in a Phase 3 trial, which utilizes artificial intelligence (AI) to ...

Ten prescription benefit managers are partnering with the White House’s TrumpRx website to offer increased transparency on the commercial, Medicare and Medicaid plan pricing of drugs featured on the ...

When lawmakers return to Washington next week, the House Energy & Commerce health subcommittee will hold a legislative hearing on several health care bills, the most notable of which is a package from ...

Health care advocates are blasting the Trump administration’s cancellation of Affordable Care Act coverage for 750,000 people, and other stakeholders are questioning the timing and impact of the ...

The Trump administration’s pick to head the key behavioral health agency and a Democratic senator butted heads over the efficacy of fentanyl test strips -- and whether they’re required to get funding ...

Senate health committee Chair Bill Cassidy (R-LA) said FDA commissioner nominee Heidi Overton will need to acknowledge that President Donald Trump’s recent comments questioning the safety of vaccines ...

The second lawsuit against CMS' interim final rule on implementing H.R. 1's Medicaid work requirements in Medicaid was filed Friday (Sept. 18) by five Medicaid beneficiaries, six provider ...

FDA’s newly proposed rule requiring food companies to disclose safety information about ingredients they determine are safe is already raising concerns among longtime regulatory attorneys and consumer ...

The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...

As the Trump administration faces backlash over its latest efforts to intensify political control over National Institutes of Health grantmaking, a group of researchers has filed a class-action ...